我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

大黄联合奥曲肽治疗急性胰腺炎的疗效分析及安全性评价*(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2017年06期
页码:
50-52,78
栏目:
临床研究
出版日期:
2018-03-19

文章信息/Info

Title:
Efficacy of Rhubarb Octreotide Rreatment of Acute Pancreatitis and Safety Evaluation
作者:
刘子梦1田炜宁2王瑞3郑粉双1杨春爱1
1. 云南省第二人民医院急诊内科,云南 昆明 650021;2. 宁夏回族自治区第五人民医院内科,宁夏 石嘴山 753000;3. 云南协华妇外专科医院内科,云南 昆明 650224
Author(s):
LIU Zimeng1 TIAN WEIning2 WANG Rui3 ZHENG Fenshuang1 YANG Chunai1
1. Department of Emergency Medicine, Second People’s Hospital of Yunnan Province, Kunming 650021, China;2. Internal Medicine, Fifth People’s Hospital of Ningxia Hui Autonomous Region, Shizuishan 753000, China;3. Department of Internal Medicine, Yunnan Union Medical College Hospital, Kunming 650224, China
关键词:
急性胰腺炎 大黄 奥曲肽 疗效 安全性
Keywords:
acute pancreatitis rhubarb octreotide efficacy safety
分类号:
R576
DOI:
10.19288/j.cnki.issn.1000-2723.2017.06.014
文献标识码:
A
摘要:
目的 探讨大黄联合西药奥曲肽治疗急性胰腺炎的临床疗效,评价其安全性,为临床治疗提供借鉴。方法 纳入急性胰腺炎患者124例,随机分为对照组和观察组,每组62例。对照组给予醋酸奥曲肽注射液治疗,观察组在对照组基础上加用中药大黄粉治疗。观察并比较两组临床疗效、APACHEⅡ评分及AMY、(LIP和Leptin水平等。)结果 观察组总有效率显著高于对照组,差异具有统计学意义(P<0.05);两组患者治疗后APACHE Ⅱ评分均显著低于各组间治疗前,且观察组APACHE Ⅱ评分显著低于对照组,差异具有统计学意义(P<0.05);观察组血清AMY和LIP水平均显著低于对照组(P<0.05),血清Leptin水平显著高于对照组,差异具有统计学意义(P<0.05);观察组发热、呕吐、腹痛消失、腹部压痛消失等症状以及住院时间均显著低于对照组,差异具有统计学意义(P<0.05)。结论 大黄联合奥曲肽治疗急性胰腺炎疗效显著,安全可靠,能有效抑制胰腺病理变化,缩短病程,改善患者预后,优于单用奥曲肽,值得临床推广应用。
Abstract:
Objective To evaluate the clinical efficacy of rhubarb combined with Western medicine octreotide treatment of acute pancreatitis, to evaluate its safety, aims to provide a reference value for clinical treatment. Methods A total of 124 cases of acute pancreatitis were randomly divided into a control group and observation group, 62 cases in each group. The control group received octreotide acetate injection treatment, observation group were based on the use of traditional Chinese medicine Rhubarb treatment. Observe and compare the clinical efficacy of the two groups of patients, APACHEⅡ score and AMY, (LIP and Leptin levels, etc.)(Note that both the hospital laboratory we did not do) Results The total effective rate was significantly higher, with statistics learn the difference(P<0.05); after treatment APACHE Ⅱ scores were significantly lower than before treatment between the groups, and the observation group APACHE Ⅱ score was significantly lower than the control group, the differences were statistically(P<0.05); observation AMY and LIP serum levels were significantly lower than the control group(P<0.05), serum Leptin levels were significantly higher, with a statistically significant difference(P<0.05); observation of fever, vomiting, abdominal pain, abdominal tenderness disappearance the symptoms and duration of hospitalization were significantly lower than the control group, with a statistically significant difference(P<0.05). Conclusion Rhubarb octreotide treatment of acute pancreatitis significant effect, safe and reliable, can effectively inhibit the pathological changes of the pancreas and duration, improve patient outcomes, better than octreotide, worthy of clinical application.

参考文献/References

[1] 芦波,钱家鸣. 重症急性胰腺炎病因及发病机制研究进展[J]. 中国实用外科杂志,2012,32(7):590-592.
[2] 王巧瑜. 芒硝外敷联合生长抑素在治疗急性胰腺炎中的应用[J]. 广东医学,2014,35(10):1567-1568.
[3] 何周桃,韩向阳. 生长抑素联合血必净对老年重症急性胰腺炎患者炎性介质的影响[J]. 中国老年学杂志,2013,33(18):4520-4521.
[4] 董秀云,徐文浩. ICU中西医结合内科治疗重症急性胰腺炎疗效观察[J]. 中国现代医学杂志,2012,22(2):88-90.
[5] 马良忠. 奥曲肽治疗急性胰腺炎疗效观察[J]. 中国实用内科杂志,2013,33(S2):32-33.
[6] 卢世云,潘秀珍. 重症急性胰腺炎发病机制研究现状[J]. 世界华人消化杂志,2011,19(23):2421-2425.
[7] 詹海勇,詹琼,詹冬雪,等. 生长抑素对急性胰腺炎患者血浆瘦素水平的影响[J]. 中国全科医学,2012,15(12):1391-1393.
[8] 李宗军. 奥曲肽联合加贝酯治疗重症急性胰腺炎临床疗效的初步探讨[J]. 重庆医科大学学报,2013,38(7):810-813.
[9] 左晓虹,陈劲梅. 奥曲肽治疗急性胰腺炎的临床疗效及对血清细胞因子的影响[J]. 细胞与分子免疫学杂志,2010,26(8):795-796.
[10] 盛颖玥,邹晓平,于成功,等. 中药大黄辅助治疗重症急性胰腺炎的系统评价[J]. 世界华人消化杂志,2010,18(7):730-735.
[11] 王武彬. 乌司他丁联合奥曲肽治疗急性胰腺炎的效果分析[J]. 海峡药学,2017,29(6):173-174.
[12] 刘金材. 奥曲肽联合生大黄治疗急性胰腺炎的临床效果[J]. 临床合理用药杂志,2016,9(36):66-67.
[13] 潘侃达,吴婵妮. 中药大承气汤联合奥曲肽治疗重症急性胰腺炎临床观察[J]. 新中医,2017,52(5):57-59.
[14] 王本贤,高军丽. 大黄联合奥曲肽治疗急性胰腺炎的临床疗效观察[J]. 内蒙古中医药,2016,35(10):40-41.
[15] 陆兴俊,李静. 奥曲肽联合生大黄外敷治疗轻度急性胰腺炎60例临床观察[J]. 中医药导报,2015,39(13):66-68.
[16] 刘红霞. 生大黄联合丹参酮ⅡA磺酸钠和奥曲肽治疗急性胰腺炎的临床效果分析[J]. 社区医学杂志,2016,14(10):44-46.
[17] 张丹丹. 奥曲肽联合丹参注射液治疗轻型急性胰腺炎的疗效观察[J]. 中国中西医结合消化杂志,2015,23(6):424-426.
[18] 饶友义,王宇,杨敏. 血栓通注射液联合奥曲肽治疗急性胰腺炎疗效的系统评价[J]. 世界临床药物,2015,36(12):838-841.
[19] 张继锋,郭峰. 乌司他丁联合奥曲肽治疗急性胰腺炎的疗效分析[J]. 中国处方药,2015,13(12):86-87.
[20] 雷正元,罗恒丽,王国俊. 奥曲肽联合大黄治疗急性胰腺炎的Meta分析[J]. 重庆医学,2015,44(24):3385-3388.

备注/Memo

备注/Memo:
* 基金项目: 昆明市科技计划重点项目(2015-2-S-01408)
收稿日期: 2017 - 10- 10
作者简介: 刘子梦(1966-),女,宁夏人,副主任医师,研究方向:急诊医学及中毒的救治。
△通信作者: 田炜宁,E-mail:TWN6095020@163.com
更新日期/Last Update: 2017-12-20